Skip to main content
Erschienen in: Supportive Care in Cancer 2/2011

01.02.2011 | Original Article

An exploration of the influences on clinical decision making and the culture of blood transfusion practise in cancer-related anaemia using an ethnographic methodology

verfasst von: Liz Bishop, Sara Faithfull, Helen Allan

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study seeks to explore the cultural practises, which shape the culture of transfusion, and to identify the key elements, which influence clinical decision making in blood transfusion in haemato-oncology and lung cancer patients.

Methods

The assessment and decision making processes for blood transfusion were explored using fieldwork observation, six patient and nine clinician interviews based on ethnographic methodology. Data were analysed using thematic analysis.

Results

First, the findings suggested that despite anaemia and transfusion being ubiquitous in this cancer setting, it sits low in the hierarchy of clinical concerns (The unimportance of anaemia). Second, there is a great deal of uncertainty surrounding the diagnosis and management of this clinical problem; but this uncertainty was acknowledged by both patients and clinicians (Acknowledging uncertainty). Third, clinicians and to some extent patients, are socialised into the practise of the sub-discipline (Socialisation in practise). Fourth, the haemoglobin level was used as a distinct fragment of information on which to assess for the presence of anaemia and base the decision to treat with blood transfusion (Disaggregation of the body).

Conclusion

The management of anaemia is not a priority in this setting; however, by understanding the complexity of factors for variation in practise in the clinical context, new models for learning transfusion skills can be developed. Furthermore, different collaborative groups could be organised to develop optimal transfusion practises, for example to include nurse-prescribing of blood components or by developing patient-centred decision making systems.
Literatur
1.
Zurück zum Zitat Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, Kosmidis P, Krazkowski M, Nortier J, Olmi P, Shneider M, Schrijvers D (2004) The European Cancer Anaemia Survey (ECAS): a large multinational, prospective survey defining the prevalence, incidence and treatment of anaemia in cancer patients. Eur J Cancer 40:2293–2306PubMedCrossRef Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, Kosmidis P, Krazkowski M, Nortier J, Olmi P, Shneider M, Schrijvers D (2004) The European Cancer Anaemia Survey (ECAS): a large multinational, prospective survey defining the prevalence, incidence and treatment of anaemia in cancer patients. Eur J Cancer 40:2293–2306PubMedCrossRef
2.
Zurück zum Zitat Bokemeyer C (2005) Therapy related causes of anaemia in cancer patients. In: Bokemeyer C, Ludwig H (eds) anaemia in cancer, 2nd edn. Elsevier Ltd, London, pp 45–83 Bokemeyer C (2005) Therapy related causes of anaemia in cancer patients. In: Bokemeyer C, Ludwig H (eds) anaemia in cancer, 2nd edn. Elsevier Ltd, London, pp 45–83
3.
Zurück zum Zitat Estrin JT, Schocket L, Kregenow R, Henry DH (1999) A retrospective view of blood transfusions in cancer patients with anaemia. The Oncologist 4:318–324PubMed Estrin JT, Schocket L, Kregenow R, Henry DH (1999) A retrospective view of blood transfusions in cancer patients with anaemia. The Oncologist 4:318–324PubMed
4.
Zurück zum Zitat Barrett-Lee PJ, Bailey NP, O’Brien MER, Wager E (2000) Large scale audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 82:93–97PubMedCrossRef Barrett-Lee PJ, Bailey NP, O’Brien MER, Wager E (2000) Large scale audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 82:93–97PubMedCrossRef
5.
Zurück zum Zitat Demetri GD (2001) Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Br J Cancer 84(suppl 1):17–23PubMed Demetri GD (2001) Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Br J Cancer 84(suppl 1):17–23PubMed
6.
7.
8.
Zurück zum Zitat Caro JJ, Salas M, Ward A, Goss G (2001) Anaemia as an independent prognostic factor for survival in patients with cancer: a systematic quantitative review. Cancer 7:2214–2221CrossRef Caro JJ, Salas M, Ward A, Goss G (2001) Anaemia as an independent prognostic factor for survival in patients with cancer: a systematic quantitative review. Cancer 7:2214–2221CrossRef
9.
Zurück zum Zitat Morisaki H, Sibbald WJ (2004) Tissue oxygen delivery and the microcirculation. Crit Care Clin 20:213–223PubMedCrossRef Morisaki H, Sibbald WJ (2004) Tissue oxygen delivery and the microcirculation. Crit Care Clin 20:213–223PubMedCrossRef
10.
Zurück zum Zitat Goodnough LT (2003) Risks of blood transfusion. Crit Care Med 31(suppl 12):678–686CrossRef Goodnough LT (2003) Risks of blood transfusion. Crit Care Med 31(suppl 12):678–686CrossRef
11.
Zurück zum Zitat Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 319:16–19PubMed Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 319:16–19PubMed
12.
Zurück zum Zitat BCSH (2001) Guidelines for the clinical use of red cell transfusions. Br J Haematol 113:24–31CrossRef BCSH (2001) Guidelines for the clinical use of red cell transfusions. Br J Haematol 113:24–31CrossRef
13.
Zurück zum Zitat Madjdpour A, Spahn C (2005) Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 95:33–42PubMedCrossRef Madjdpour A, Spahn C (2005) Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 95:33–42PubMedCrossRef
14.
Zurück zum Zitat Wigton RS, Hoellerich VL, Patil KD (1999) How physicians use clinical information in diagnosing pulmonary embolism: an application of conjoint analysis. In: Dowie J, Elstein A (eds) Professional Judgment: a reader in clinical decision making, 6th edn. Cambridge University Press, Cambridge, pp 130–149 Wigton RS, Hoellerich VL, Patil KD (1999) How physicians use clinical information in diagnosing pulmonary embolism: an application of conjoint analysis. In: Dowie J, Elstein A (eds) Professional Judgment: a reader in clinical decision making, 6th edn. Cambridge University Press, Cambridge, pp 130–149
15.
Zurück zum Zitat Salem-Schatz SR, Avorn J, Soumarai SB (1993) Influence of knowledge and attitudes on the quality of physicians’ transfusion practice. Med Care 31:868–878PubMedCrossRef Salem-Schatz SR, Avorn J, Soumarai SB (1993) Influence of knowledge and attitudes on the quality of physicians’ transfusion practice. Med Care 31:868–878PubMedCrossRef
16.
17.
Zurück zum Zitat Spradley JP (1980) Participant Observation. Thomson Learning, Belmont Spradley JP (1980) Participant Observation. Thomson Learning, Belmont
18.
Zurück zum Zitat Hammersley M, Atkinson P (2007) Ethnography: principles in practice, 3rd edn. Routledge, London Hammersley M, Atkinson P (2007) Ethnography: principles in practice, 3rd edn. Routledge, London
19.
Zurück zum Zitat Atkinson P (1995) Medical talk and medical work. Sage Publications, London Atkinson P (1995) Medical talk and medical work. Sage Publications, London
20.
Zurück zum Zitat Foubert J, Wujcik D (2005) Nursing assessment and management of anaemia and fatigue. In: Bokemeyer C, Ludwig H (eds) Anaemia in cancer, 2nd edn. Elsevier Ltd, London, pp 105–121 Foubert J, Wujcik D (2005) Nursing assessment and management of anaemia and fatigue. In: Bokemeyer C, Ludwig H (eds) Anaemia in cancer, 2nd edn. Elsevier Ltd, London, pp 105–121
21.
Zurück zum Zitat Eddy DM (1999) Variations in physician practice: the role of uncertainty. In: Dowie J, Elstein A (eds) Professional judgment: a reader in clinical decision making, 6th edn. Cambridge University Press, Cambridge, pp 1–45 Eddy DM (1999) Variations in physician practice: the role of uncertainty. In: Dowie J, Elstein A (eds) Professional judgment: a reader in clinical decision making, 6th edn. Cambridge University Press, Cambridge, pp 1–45
22.
23.
Zurück zum Zitat Giddens A (2006) Sociology. Polity Press, London Giddens A (2006) Sociology. Polity Press, London
24.
Zurück zum Zitat Manley K, Mc Cormack B (2008) Person-centred care. Nurs Manage 15:12–13 Manley K, Mc Cormack B (2008) Person-centred care. Nurs Manage 15:12–13
Metadaten
Titel
An exploration of the influences on clinical decision making and the culture of blood transfusion practise in cancer-related anaemia using an ethnographic methodology
verfasst von
Liz Bishop
Sara Faithfull
Helen Allan
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0801-5

Weitere Artikel der Ausgabe 2/2011

Supportive Care in Cancer 2/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.